We serve (6-diphenylphosphanyl-10H-phenoxazin-4-yl)-diphenylphosphane CAS:261733-18-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: (6-diphenylphosphanyl-10H-phenoxazin-4-yl)-diphenylphosphane
CAS.NO:261733-18-0
Molecular Formula:C36H27NOP2
Molecular Weight:551.55300
Synonyms:
4,6-BIS(DIPHENYLPHOSPHINO)PHENOXAZINE
4,6-Bis(diphenylphosphino)-10H-phenoxazine
NIXANTPHOS
Physical and Chemical Properties:
Density: /
Boiling point: 662.1ºC at 760mmHg
Melting point: 256-262ºC
Flash point: 354.3ºC
Refractive index: /
Specification:
Appearance:White to tan crystals or powder
Purity:≥98%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:4,6-Bis(Diphenylphosphino)phenoxazine is used as a palladium catalyst in reactions involving the synthesis of triarylmethanes.
Contact us for information like (6-diphenylphosphanyl-10H-phenoxazin-4-yl)-diphenylphosphane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,NIXANTPHOS physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,6-BIS(DIPHENYLPHOSPHINO)PHENOXAZINE Use and application,4,6-Bis(diphenylphosphino)-10H-phenoxazine technical grade,usp/ep/jp grade.
Related News: Hong Kong confirmed its 14th coronavirus case late Saturday. The patient, an 80-year-old man, had traveled for a few hours to mainland China in early January, and later spent several days on a cruise ship in Japan with more than 3,000 passengers and employees.Triphenylphosphine manufacturer The two institutes that discovered Shuanghuanglian’s alleged ability to “inhibit” the coronavirus are both state-run bodies.4-Bromo-9H-carbazole supplier The two institutes that discovered Shuanghuanglian’s alleged ability to “inhibit” the coronavirus are both state-run bodies.L-Aspartic Acid vendor INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.
